This review examines how microfluidics has been used in the formulation, preclinical, and clinical development of gene-delivery nanoparticles.
Shell Ip
Advertisement
Shell Ip, PhD, is a technical marketing specialist at Precision Nanosystems.
Articles by Shell Ip
Advertisement
Latest Updated Articles
Accelerating Genetic Medicine R&D Using MicrofluidicsSeptember 15th 2017
Advertisement
Advertisement
Trending on BioPharm International
1
Zai Lab’s Long-Acting Atopic Dermatitis Bispecific Points to Every-12-Week Dosin
2
FDA Reportedly Pauses National Priority Voucher Pilot and Pauses CRL Publication
3
FDA Grants Kamau RMAT Designation to Nula-cel for Sickle Cell Disease
4
The BioPharm Brief: FDA’s Fast-Track Pilot Reportedly Stalls, a Long-Acting Bispecific for Atopic Dermatitis, and a Twice-Yearly Obesity Approach
5